Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


00


Reuters

Latest News

Reuters: Italy says Malta not taking in migrant ship is 'inhumane'

Reuters: US STOCKS SNAPSHOT-Dow snaps losing streak, helped by energy; Nasdaq falls

NewYorkTimes: Downtown-Facing Yoga Pose

FOX: Prep school says it will pay for abused alumni's therapy

FOX: Prep school says it will pay for abused alumni's therapy

FOX: Ex-North Carolina governor barks at successor over sculpture

FOX: Texas Tech condemns racist remarks students allegedly posted

FOX: American Bible Society: No sex before marriage

FOX: Fired for being gay: How it’s legal in 28 states

CBS: "Cadillac Frank," ex-New England Mafia boss, guilty in slaying

CBC: Jerusalem backlash casts shadow over Eurovision contest

BBC: Great Exhibition of the North: Steam engines mark opening

Los Angeles Times: Hashtag Highlights: Outcries for separated families, goodbyes to 'Game of Thrones'

Los Angeles Times: George Carlin's comedy 'stuff' finds new homes in a DVD anthology — and in a museum

USA Today: Landmark win as Novak Djokovic reaches Queen's semis

USA Today: Immigrant kids crying audio played on House floor

USA Today: Supreme Court hands Big Brother a defeat on cellphone privacy

USA Today: Crude oil leaks from derailed train in Iowa

Daily Mail: Texas Tech condemns racist remarks students allegedly...

Daily Mail: Ex-North Carolina governor barks at successor over...

Daily Mail: Trump trots out families who were 'permanently separated' from their relatives by illegal immigrants

Daily Mail: Mom charged over one-year-old daughter's hot car death

Daily Mail: Italy says Malta not taking in migrant ship is "inhumane"